{"schema_version":"secwatch.event_recent.v1","event_type":"regulatory","label":"Regulatory","canonical_url":"https://secwatch.observer/events/regulatory/recent","rss_url":"https://secwatch.observer/feed/event/regulatory.xml","filings":[{"accession":"0001493152-26-030342","filed_at":"2026-06-26T21:15:40+00:00","ticker":"MTNB","company_name":"Matinas BioPharma Holdings, Inc.","headline":"Matinas BioPharma receives NYSE American non-compliance notice; granted plan period through Oct 2027","event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"materiality_score_display":"0.70","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315226030342/0001493152-26-030342-index.htm","json_url":"/filing/0001493152-26-030342.json","markdown_url":"/filing/0001493152-26-030342.md","text_url":"/filing/0001493152-26-030342.txt"},{"accession":"0001104659-26-078317","filed_at":"2026-06-26T21:00:22+00:00","ticker":"AEE","company_name":"AMEREN CORP","headline":"Ameren Missouri files $343M electric rate increase request with MoPSC","event_type":"regulatory","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"materiality_score_display":"0.60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1002910/000110465926078317/0001104659-26-078317-index.htm","json_url":"/filing/0001104659-26-078317.json","markdown_url":"/filing/0001104659-26-078317.md","text_url":"/filing/0001104659-26-078317.txt"},{"accession":"0001477932-26-004047","filed_at":"2026-06-26T20:35:59+00:00","ticker":"UPXI","company_name":"UPEXI, INC.","headline":"Upexi receives Nasdaq delisting notice over unapproved convertible notes; joins Russell Microcap Index","event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"materiality_score_display":"0.70","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1775194/000147793226004047/0001477932-26-004047-index.htm","json_url":"/filing/0001477932-26-004047.json","markdown_url":"/filing/0001477932-26-004047.md","text_url":"/filing/0001477932-26-004047.txt"},{"accession":"0001213900-26-072597","filed_at":"2026-06-26T20:05:17+00:00","ticker":"CHAR","company_name":"Charlton Aria Acquisition Corp","headline":"Charlton Aria resolves Nasdaq filing deficiency; compliance matter closed","event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"materiality_score_display":"0.55","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/2024459/000121390026072597/0001213900-26-072597-index.htm","json_url":"/filing/0001213900-26-072597.json","markdown_url":"/filing/0001213900-26-072597.md","text_url":"/filing/0001213900-26-072597.txt"},{"accession":"0001104659-26-078009","filed_at":"2026-06-26T12:14:23+00:00","ticker":"REPL","company_name":"Replimune Group, Inc.","headline":"FDA accepts Replimune's BLA resubmission for RP1 in advanced melanoma; decision by Aug 2","event_type":"regulatory","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"materiality_score_display":"0.80","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465926078009/0001104659-26-078009-index.htm","json_url":"/filing/0001104659-26-078009.json","markdown_url":"/filing/0001104659-26-078009.md","text_url":"/filing/0001104659-26-078009.txt"},{"accession":"0001651308-26-000020","filed_at":"2026-06-26T10:02:23+00:00","ticker":"ONC","company_name":"BeOne Medicines Ltd.","headline":"BeOne Medicines settles China tax audit; pays ~RMB 446M in Q2 2026","event_type":"regulatory","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"materiality_score_display":"0.65","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130826000020/0001651308-26-000020-index.htm","json_url":"/filing/0001651308-26-000020.json","markdown_url":"/filing/0001651308-26-000020.md","text_url":"/filing/0001651308-26-000020.txt"},{"accession":"0001493152-26-030205","filed_at":"2026-06-25T23:36:23+00:00","ticker":"EXOZ","company_name":"EXOZYMES INC.","headline":"eXoZymes receives $2M NIH Phase IIB SBIR grant for cannabinoid analog drug discovery","event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"materiality_score_display":"0.60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226030205/0001493152-26-030205-index.htm","json_url":"/filing/0001493152-26-030205.json","markdown_url":"/filing/0001493152-26-030205.md","text_url":"/filing/0001493152-26-030205.txt"},{"accession":"0001213900-26-072137","filed_at":"2026-06-25T21:12:22+00:00","ticker":"HOTH","company_name":"Hoth Therapeutics, Inc.","headline":"Rocket One regains Nasdaq minimum bid price compliance","event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"materiality_score_display":"0.50","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1711786/000121390026072137/0001213900-26-072137-index.htm","json_url":"/filing/0001213900-26-072137.json","markdown_url":"/filing/0001213900-26-072137.md","text_url":"/filing/0001213900-26-072137.txt"},{"accession":"0001193125-26-282988","filed_at":"2026-06-25T21:00:14+00:00","ticker":"HRTX","company_name":"HERON THERAPEUTICS, INC. /DE/","headline":"Heron Therapeutics receives Nasdaq notice for bid price below $1.00; 180 days to cure","event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"materiality_score_display":"0.75","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526282988/0001193125-26-282988-index.htm","json_url":"/filing/0001193125-26-282988.json","markdown_url":"/filing/0001193125-26-282988.md","text_url":"/filing/0001193125-26-282988.txt"},{"accession":"0000004962-26-000281","filed_at":"2026-06-25T20:19:46+00:00","ticker":"AXP","company_name":"AMERICAN EXPRESS CO","headline":"American Express DFAST: Fed maintains minimum 2.5% SCB through Sep 2027","event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"materiality_score_display":"0.60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/4962/000000496226000281/0000004962-26-000281-index.htm","json_url":"/filing/0000004962-26-000281.json","markdown_url":"/filing/0000004962-26-000281.md","text_url":"/filing/0000004962-26-000281.txt"},{"accession":"0001493152-26-030124","filed_at":"2026-06-25T20:15:17+00:00","ticker":"NNE","company_name":"Nano Nuclear Energy Inc.","headline":"U.S. NRC begins formal review of Nano Nuclear's KRONOS MMR construction permit for UIUC deployment","event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"materiality_score_display":"0.65","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1923891/000149315226030124/0001493152-26-030124-index.htm","json_url":"/filing/0001493152-26-030124.json","markdown_url":"/filing/0001493152-26-030124.md","text_url":"/filing/0001493152-26-030124.txt"},{"accession":"0001104659-26-077584","filed_at":"2026-06-25T13:26:59+00:00","ticker":"CTSO","company_name":"Cytosorbents Corp","headline":"CytoSorbents schedules two FDA pre-submission meetings for ticagrelor and DOAC programs in August 2026","event_type":"regulatory","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"materiality_score_display":"0.55","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465926077584/0001104659-26-077584-index.htm","json_url":"/filing/0001104659-26-077584.json","markdown_url":"/filing/0001104659-26-077584.md","text_url":"/filing/0001104659-26-077584.txt"},{"accession":"0001213900-26-071745","filed_at":"2026-06-25T11:31:00+00:00","ticker":"IXHL","company_name":"Incannex Healthcare Inc.","headline":"Incannex granted US patent covering IHL-42X for obstructive sleep apnea through 2040","event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"materiality_score_display":"0.70","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026071745/0001213900-26-071745-index.htm","json_url":"/filing/0001213900-26-071745.json","markdown_url":"/filing/0001213900-26-071745.md","text_url":"/filing/0001213900-26-071745.txt"},{"accession":"0000036104-26-000035","filed_at":"2026-06-24T21:30:14+00:00","ticker":"USB","company_name":"US BANCORP DE","headline":"U.S. Bancorp Stress Capital Buffer unchanged at 2.6%, plans dividend increase to $0.54/share","event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"materiality_score_display":"0.60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/36104/000003610426000035/0000036104-26-000035-index.htm","json_url":"/filing/0000036104-26-000035.json","markdown_url":"/filing/0000036104-26-000035.md","text_url":"/filing/0000036104-26-000035.txt"},{"accession":"0001493152-26-029963","filed_at":"2026-06-24T21:23:15+00:00","ticker":"SRXH","company_name":"SRx Health Solutions, Inc.","headline":"SRX Global receives NYSE American delisting notice; approves 1-for-60 reverse split effective July 6","event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"materiality_score_display":"0.75","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1471727/000149315226029963/0001493152-26-029963-index.htm","json_url":"/filing/0001493152-26-029963.json","markdown_url":"/filing/0001493152-26-029963.md","text_url":"/filing/0001493152-26-029963.txt"},{"accession":"0001104659-26-077347","filed_at":"2026-06-24T21:05:18+00:00","ticker":"CWCO","company_name":"Consolidated Water Co. Ltd.","headline":"Consolidated Water subsidiary receives new 25-year license with lower water rates","event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"materiality_score_display":"0.85","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/928340/000110465926077347/0001104659-26-077347-index.htm","json_url":"/filing/0001104659-26-077347.json","markdown_url":"/filing/0001104659-26-077347.md","text_url":"/filing/0001104659-26-077347.txt"},{"accession":"0001628280-26-045169","filed_at":"2026-06-24T20:07:40+00:00","ticker":"JPM","company_name":"JPMORGAN CHASE & CO","headline":"JPMorgan Chase reports 2026 DFAST results; CET1 ratio minimum 12.4% under severe stress","event_type":"regulatory","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"materiality_score_display":"0.65","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/19617/000162828026045169/0001628280-26-045169-index.htm","json_url":"/filing/0001628280-26-045169.json","markdown_url":"/filing/0001628280-26-045169.md","text_url":"/filing/0001628280-26-045169.txt"},{"accession":"0001140361-26-026232","filed_at":"2026-06-24T19:48:37+00:00","ticker":"IONS","company_name":"IONIS PHARMACEUTICALS INC","headline":"FDA approves Ionis' TRYNGOLZA for severe hypertriglyceridemia, cuts pancreatitis risk 91%","event_type":"regulatory","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"materiality_score_display":"0.85","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/874015/000114036126026232/0001140361-26-026232-index.htm","json_url":"/filing/0001140361-26-026232.json","markdown_url":"/filing/0001140361-26-026232.md","text_url":"/filing/0001140361-26-026232.txt"},{"accession":"0001213900-26-071380","filed_at":"2026-06-24T15:36:37+00:00","ticker":"ADTX","company_name":"Aditxt, Inc.","headline":"Nasdaq Panel denies Aditxt listing; trading suspended June 25, 2026","event_type":"regulatory","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"materiality_score_display":"0.95","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026071380/0001213900-26-071380-index.htm","json_url":"/filing/0001213900-26-071380.json","markdown_url":"/filing/0001213900-26-071380.md","text_url":"/filing/0001213900-26-071380.txt"},{"accession":"0001627223-26-000017","filed_at":"2026-06-24T14:48:32+00:00","ticker":"CC","company_name":"Chemours Co","headline":"Chemours agrees to $22.5M penalty and $90M in PFAS mitigation projects to settle EPA claims","event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"materiality_score_display":"0.75","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000162722326000017/0001627223-26-000017-index.htm","json_url":"/filing/0001627223-26-000017.json","markdown_url":"/filing/0001627223-26-000017.md","text_url":"/filing/0001627223-26-000017.txt"},{"accession":"0001140361-26-026169","filed_at":"2026-06-24T13:35:41+00:00","ticker":"FEMY","company_name":"FEMASYS INC","headline":"Femasys regains compliance with Nasdaq minimum bid price rule after reverse stock split","event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"materiality_score_display":"0.60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036126026169/0001140361-26-026169-index.htm","json_url":"/filing/0001140361-26-026169.json","markdown_url":"/filing/0001140361-26-026169.md","text_url":"/filing/0001140361-26-026169.txt"},{"accession":"0001104659-26-077060","filed_at":"2026-06-24T11:39:06+00:00","ticker":"CGTX","company_name":"COGNITION THERAPEUTICS INC","headline":"Cognition Therapeutics receives FDA alignment on pivotal trial design for zervimesine in DLB psychosis","event_type":"regulatory","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"materiality_score_display":"0.80","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926077060/0001104659-26-077060-index.htm","json_url":"/filing/0001104659-26-077060.json","markdown_url":"/filing/0001104659-26-077060.md","text_url":"/filing/0001104659-26-077060.txt"},{"accession":"0001829126-26-006773","filed_at":"2026-06-23T21:00:27+00:00","ticker":"NTHI","company_name":"NEONC TECHNOLOGIES HOLDINGS, INC.","headline":"NeOnc receives UAE IND approval for NEO100; Phase 2a data expected by end of July 2026","event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"materiality_score_display":"0.55","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1979414/000182912626006773/0001829126-26-006773-index.htm","json_url":"/filing/0001829126-26-006773.json","markdown_url":"/filing/0001829126-26-006773.md","text_url":"/filing/0001829126-26-006773.txt"},{"accession":"0001140361-26-026092","filed_at":"2026-06-23T20:16:00+00:00","ticker":"DEVS","company_name":"DevvStream Corp.","headline":"DevvStream receives Nasdaq delisting determination; trading suspended June 24, 2026","event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"materiality_score_display":"0.85","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1854480/000114036126026092/0001140361-26-026092-index.htm","json_url":"/filing/0001140361-26-026092.json","markdown_url":"/filing/0001140361-26-026092.md","text_url":"/filing/0001140361-26-026092.txt"},{"accession":"0001104659-26-076822","filed_at":"2026-06-23T20:15:28+00:00","ticker":"QNRX","company_name":"Quoin Pharmaceuticals, Ltd.","headline":"Quoin Pharma gets FDA conditional approval of brand name QYLEKI for Netherton Syndrome candidate","event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"materiality_score_display":"0.55","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926076822/0001104659-26-076822-index.htm","json_url":"/filing/0001104659-26-076822.json","markdown_url":"/filing/0001104659-26-076822.md","text_url":"/filing/0001104659-26-076822.txt"},{"accession":"0001493152-26-029781","filed_at":"2026-06-23T20:05:34+00:00","ticker":"TONX","company_name":"TON Strategy Co","headline":"TON Strategy receives Nasdaq reprimand for excess equity awards; listing continues","event_type":"regulatory","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"materiality_score_display":"0.50","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1566610/000149315226029781/0001493152-26-029781-index.htm","json_url":"/filing/0001493152-26-029781.json","markdown_url":"/filing/0001493152-26-029781.md","text_url":"/filing/0001493152-26-029781.txt"},{"accession":"0001213900-26-071082","filed_at":"2026-06-23T20:05:25+00:00","ticker":"INMB","company_name":"Inmune Bio, Inc.","headline":"MHRA aligns with INmune Bio on regulatory path for Ebstrocel in RDEB; UK MAA planned in 2026","event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"materiality_score_display":"0.75","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026071082/0001213900-26-071082-index.htm","json_url":"/filing/0001213900-26-071082.json","markdown_url":"/filing/0001213900-26-071082.md","text_url":"/filing/0001213900-26-071082.txt"},{"accession":"0001437749-26-021428","filed_at":"2026-06-23T20:00:51+00:00","ticker":"SMSI","company_name":"SMITH MICRO SOFTWARE, INC.","headline":"Smith Micro regains Nasdaq minimum bid price compliance after stock closes above $1.00 for 10 days","event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"materiality_score_display":"0.65","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/948708/000143774926021428/0001437749-26-021428-index.htm","json_url":"/filing/0001437749-26-021428.json","markdown_url":"/filing/0001437749-26-021428.md","text_url":"/filing/0001437749-26-021428.txt"},{"accession":"0001213900-26-071062","filed_at":"2026-06-23T19:43:02+00:00","ticker":"WORX","company_name":"SCWorx Corp.","headline":"SCWorx secures Nasdaq listing continuation subject to reverse stock split and bid price compliance by Aug 28","event_type":"regulatory","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"materiality_score_display":"0.60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1674227/000121390026071062/0001213900-26-071062-index.htm","json_url":"/filing/0001213900-26-071062.json","markdown_url":"/filing/0001213900-26-071062.md","text_url":"/filing/0001213900-26-071062.txt"},{"accession":"0001140361-26-026031","filed_at":"2026-06-23T11:51:12+00:00","ticker":"GALT","company_name":"GALECTIN THERAPEUTICS INC","headline":"Galectin reaches FDA agreement on Phase 3 endpoint for belapectin in MASH cirrhosis","event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"materiality_score_display":"0.75","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1133416/000114036126026031/0001140361-26-026031-index.htm","json_url":"/filing/0001140361-26-026031.json","markdown_url":"/filing/0001140361-26-026031.md","text_url":"/filing/0001140361-26-026031.txt"},{"accession":"0000072903-26-000109","filed_at":"2026-06-22T23:53:52+00:00","ticker":null,"company_name":"SOUTHWESTERN PUBLIC SERVICE CO","headline":"SPS reaches $90M rate increase stipulation in NMPRC case; Xcel reaffirms EPS guidance","event_type":"regulatory","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"materiality_score_display":"0.70","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/92521/000007290326000109/0000072903-26-000109-index.htm","json_url":"/filing/0000072903-26-000109.json","markdown_url":"/filing/0000072903-26-000109.md","text_url":"/filing/0000072903-26-000109.txt"},{"accession":"0001689548-26-000066","filed_at":"2026-06-22T20:43:01+00:00","ticker":"PRAX","company_name":"Praxis Precision Medicines, Inc.","headline":"FDA grants Breakthrough Therapy Designation for Praxis Precision Medicines' elsunersen for SCN2A-DEE","event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"materiality_score_display":"0.70","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000066/0001689548-26-000066-index.htm","json_url":"/filing/0001689548-26-000066.json","markdown_url":"/filing/0001689548-26-000066.md","text_url":"/filing/0001689548-26-000066.txt"},{"accession":"0001193125-26-277506","filed_at":"2026-06-22T20:05:06+00:00","ticker":"SPRO","company_name":"Spero Therapeutics, Inc.","headline":"FDA approves Spero Therapeutics' Utebzi, first oral carbapenem for cUTIs","event_type":"regulatory","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"materiality_score_display":"0.90","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312526277506/0001193125-26-277506-index.htm","json_url":"/filing/0001193125-26-277506.json","markdown_url":"/filing/0001193125-26-277506.md","text_url":"/filing/0001193125-26-277506.txt"},{"accession":"0001437749-26-021306","filed_at":"2026-06-22T20:02:03+00:00","ticker":"HYFM","company_name":"HYDROFARM HOLDINGS GROUP, INC.","headline":"Hydrofarm gets Nasdaq extension to meet equity rule; must close strategic deals","event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"materiality_score_display":"0.65","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1695295/000143774926021306/0001437749-26-021306-index.htm","json_url":"/filing/0001437749-26-021306.json","markdown_url":"/filing/0001437749-26-021306.md","text_url":"/filing/0001437749-26-021306.txt"},{"accession":"0001793229-26-000056","filed_at":"2026-06-22T20:01:26+00:00","ticker":"CTEV","company_name":"Claritev Corp","headline":"Claritev DOJ criminal investigation closed; civil probe ongoing","event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"materiality_score_display":"0.70","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1793229/000179322926000056/0001793229-26-000056-index.htm","json_url":"/filing/0001793229-26-000056.json","markdown_url":"/filing/0001793229-26-000056.md","text_url":"/filing/0001793229-26-000056.txt"},{"accession":"0000072903-26-000107","filed_at":"2026-06-22T11:08:51+00:00","ticker":null,"company_name":"NORTHERN STATES POWER CO","headline":"MPUC approves $211M rate increase for Xcel's NSP-Minnesota; ROE rises to 9.60%","event_type":"regulatory","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"materiality_score_display":"0.60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1123852/000007290326000107/0000072903-26-000107-index.htm","json_url":"/filing/0000072903-26-000107.json","markdown_url":"/filing/0000072903-26-000107.md","text_url":"/filing/0000072903-26-000107.txt"},{"accession":"0000879169-26-000046","filed_at":"2026-06-22T11:00:40+00:00","ticker":"INCY","company_name":"INCYTE CORP","headline":"Incyte settles CMS dispute over Opzelura Medicaid rebates; records $246M benefit","event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"materiality_score_display":"0.75","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/879169/000087916926000046/0000879169-26-000046-index.htm","json_url":"/filing/0000879169-26-000046.json","markdown_url":"/filing/0000879169-26-000046.md","text_url":"/filing/0000879169-26-000046.txt"},{"accession":"0001104659-26-076058","filed_at":"2026-06-22T11:00:29+00:00","ticker":"TRAW","company_name":"Traws Pharma, Inc.","headline":"Traws Pharma to resubmit TXM data package to UK MHRA in Q3 2026 for Phase 2a influenza challenge study","event_type":"regulatory","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"materiality_score_display":"0.40","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1130598/000110465926076058/0001104659-26-076058-index.htm","json_url":"/filing/0001104659-26-076058.json","markdown_url":"/filing/0001104659-26-076058.md","text_url":"/filing/0001104659-26-076058.txt"},{"accession":"0001213900-26-070212","filed_at":"2026-06-18T21:15:27+00:00","ticker":"SILO","company_name":"Silo Pharma, Inc.","headline":"Silo Pharma regains compliance with Nasdaq minimum bid price rule","event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"materiality_score_display":"0.50","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390026070212/0001213900-26-070212-index.htm","json_url":"/filing/0001213900-26-070212.json","markdown_url":"/filing/0001213900-26-070212.md","text_url":"/filing/0001213900-26-070212.txt"},{"accession":"0001829126-26-006688","filed_at":"2026-06-18T21:00:18+00:00","ticker":"NTHI","company_name":"NEONC TECHNOLOGIES HOLDINGS, INC.","headline":"NeOnc Technologies gets UAE IND approval for NEO212 brain cancer drug","event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"materiality_score_display":"0.65","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1979414/000182912626006688/0001829126-26-006688-index.htm","json_url":"/filing/0001829126-26-006688.json","markdown_url":"/filing/0001829126-26-006688.md","text_url":"/filing/0001829126-26-006688.txt"},{"accession":"0001824293-26-000050","filed_at":"2026-06-18T20:50:36+00:00","ticker":"GRI","company_name":"GRI Bio, Inc.","headline":"GRI Bio receives FDA Orphan Drug Designation for GRI-0621 in IPF","event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"materiality_score_display":"0.70","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429326000050/0001824293-26-000050-index.htm","json_url":"/filing/0001824293-26-000050.json","markdown_url":"/filing/0001824293-26-000050.md","text_url":"/filing/0001824293-26-000050.txt"},{"accession":"0001493152-26-029347","filed_at":"2026-06-18T20:30:45+00:00","ticker":"RIME","company_name":"Algorhythm Holdings, Inc.","headline":"Algorhythm receives Nasdaq bid-price deficiency notice; 180-day cure period","event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"materiality_score_display":"0.70","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/923601/000149315226029347/0001493152-26-029347-index.htm","json_url":"/filing/0001493152-26-029347.json","markdown_url":"/filing/0001493152-26-029347.md","text_url":"/filing/0001493152-26-029347.txt"},{"accession":"0001801170-26-000166","filed_at":"2026-06-18T20:05:28+00:00","ticker":"CLOV","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","headline":"Clover Health's Medicare Advantage contracts upgraded to 4.5 Stars for payment year 2027","event_type":"regulatory","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"materiality_score_display":"0.80","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000166/0001801170-26-000166-index.htm","json_url":"/filing/0001801170-26-000166.json","markdown_url":"/filing/0001801170-26-000166.md","text_url":"/filing/0001801170-26-000166.txt"},{"accession":"0001493152-26-029214","filed_at":"2026-06-18T13:55:31+00:00","ticker":"DYAI","company_name":"DYADIC INTERNATIONAL INC","headline":"Dyadic receives Nasdaq delisting notice for bid price and continued listing deficiencies","event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"materiality_score_display":"0.85","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1213809/000149315226029214/0001493152-26-029214-index.htm","json_url":"/filing/0001493152-26-029214.json","markdown_url":"/filing/0001493152-26-029214.md","text_url":"/filing/0001493152-26-029214.txt"},{"accession":"0001213900-26-069902","filed_at":"2026-06-18T13:02:06+00:00","ticker":"CVKD","company_name":"Cadrenal Therapeutics, Inc.","headline":"Cadrenal to file for FDA Rare Pediatric Disease Designation for tecarfarin in Kawasaki","event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"materiality_score_display":"0.65","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026069902/0001213900-26-069902-index.htm","json_url":"/filing/0001213900-26-069902.json","markdown_url":"/filing/0001213900-26-069902.md","text_url":"/filing/0001213900-26-069902.txt"},{"accession":"0000728391-26-000031","filed_at":"2026-06-17T21:11:08+00:00","ticker":null,"company_name":"IPALCO ENTERPRISES, INC.","headline":"IURC approves AES Indiana base rate settlement; $1.98B revenue, 9.5% ROE","event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"materiality_score_display":"0.70","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/728391/000072839126000031/0000728391-26-000031-index.htm","json_url":"/filing/0000728391-26-000031.json","markdown_url":"/filing/0000728391-26-000031.md","text_url":"/filing/0000728391-26-000031.txt"},{"accession":"0000827187-26-000053","filed_at":"2026-06-17T21:07:37+00:00","ticker":"SNBR","company_name":"Sleep Number Corp","headline":"Sleep Number receives Nasdaq delisting notice after Chapter 11 filing; trading suspended June 23","event_type":"regulatory","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"materiality_score_display":"1.00","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/827187/000082718726000053/0000827187-26-000053-index.htm","json_url":"/filing/0000827187-26-000053.json","markdown_url":"/filing/0000827187-26-000053.md","text_url":"/filing/0000827187-26-000053.txt"},{"accession":"0001193125-26-274258","filed_at":"2026-06-17T20:36:46+00:00","ticker":"CORT","company_name":"CORCEPT THERAPEUTICS INC","headline":"Corcept resubmits NDA for relacorilant to FDA for Cushing's syndrome; six-month review expected","event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"materiality_score_display":"0.75","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526274258/0001193125-26-274258-index.htm","json_url":"/filing/0001193125-26-274258.json","markdown_url":"/filing/0001193125-26-274258.md","text_url":"/filing/0001193125-26-274258.txt"},{"accession":"0001193125-26-274110","filed_at":"2026-06-17T20:02:07+00:00","ticker":"GENC","company_name":"GENCOR INDUSTRIES INC","headline":"Gencor regains NYSE American listing compliance after filing delayed Q1 10-Q","event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"materiality_score_display":"0.60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/64472/000119312526274110/0001193125-26-274110-index.htm","json_url":"/filing/0001193125-26-274110.json","markdown_url":"/filing/0001193125-26-274110.md","text_url":"/filing/0001193125-26-274110.txt"},{"accession":"0001493152-26-028992","filed_at":"2026-06-17T12:00:39+00:00","ticker":"MIRA","company_name":"MIRA PHARMACEUTICALS, INC.","headline":"MIRA submits Phase 2a protocol to FDA for Ketamir-2 in CIPN","event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"materiality_score_display":"0.60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226028992/0001493152-26-028992-index.htm","json_url":"/filing/0001493152-26-028992.json","markdown_url":"/filing/0001493152-26-028992.md","text_url":"/filing/0001493152-26-028992.txt"}]}